Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for institutions that develop training programs in Alzheimer's disease and dementia research. Eligible applicants include universities, HBCUs, HSIs, TCCUs, tribal governments, and faith-based organizations.
Trainees must be at the predoctoral or postdoctoral level with diverse educational backgrounds. Programs should provide interdisciplinary training in data science, disease biology, behavioral research, and drug discovery.
Clinical trials are not allowed under this program. Non-U.S. entities and foreign organizations cannot apply. Programs must prepare researchers to conduct rigorous basic, translational, and clinical research on AD/ADRD.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer’s disease and Alzheimer’s-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- County Government
- Faith-based Organization
- HBCU
- HSI (Hispanic Serving Institution)
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Small Business (SBA-defined)
- Special District
- State Government
- TCU (Tribal Colleges)
- Tribal Nation
- Tribal Organization
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (R&R)
- Project Narrative
- Detailed Budget and Budget Justification
- Institutional Support Letter
- Mentor/Faculty Biographical Sketches
- Training Program Description
- Letters of Support from Department/Institution Leadership
- Timeline for Trainee Development
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.866 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$463,372,200
-
$172,327,224
-
$115,145,694
-
$99,649,073
-
$93,275,174
-
$82,572,681
-
$81,344,612
-
$78,657,309
-
$75,825,492
-
$75,398,895
Top States by Funding
- CA 10 awards $633.7M
- MI 2 awards $511.9M
- MO 8 awards $453.5M
- IN 4 awards $303.9M
- PA 6 awards $298.0M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.866). How funding has trended year over year.
| 2024 | $3,746,886,731 | |
| 2025 | $3,777,464,644 | |
| 2026 est. | $261,814,471 |
FAQ
What types of institutions can apply?
Universities, HBCUs, HSIs, TCCUs, tribal governments, and faith-based organizations are eligible. Foreign organizations and non-domestic components of U.S. organizations cannot apply.
Who can be trained under this program?
Predoctoral and postdoctoral researchers with diverse educational backgrounds including basic biology, translational research, clinical research, and data science.
What should the training program cover?
Programs must teach data science, disease biology, behavioral research, and traditional and emerging drug discovery methods for AD/ADRD research.
Are clinical trials allowed?
No, clinical trials are explicitly not allowed under this funding opportunity.
What is the application deadline?
The deadline is September 25, 2026, with no rolling acceptance indicated.
💡 Tips for applicants
- Emphasize your institution's interdisciplinary strengths across biology, clinical research, and data science. Strong partnerships between departments strengthen applications.
- Detail how your program will recruit and support diverse trainees. Address specific recruitment and retention strategies.
- Show how trainees will gain hands-on experience in drug discovery and translational research methods. Include mentor qualifications and research infrastructure.
- Connect your program to workforce gaps in AD/ADRD research. Explain how your graduates will advance the field.
- Include evidence of institutional commitment through dedicated resources, space, and administrative support for the training program.
⚠️ Common mistakes
Failing to demonstrate genuine interdisciplinary collaboration across basic biology, translational, clinical, and data science research areas. Proposing activities that resemble clinical trials or direct patient care rather than workforce development. Weak institutional commitment with insufficient dedicated resources, mentorship structure, or trainee support mechanisms.
Similar grants
- OPEN NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed) — National Institutes of Health
- OPEN NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed) — National Institutes of Health
- CLOSED Resource-Related Research Projects Cooperative Agreements in Aging and/or Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) Research — National Institutes of Health
- CLOSED Specialized Center Cooperative Agreements in Aging and/or Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Research — National Institutes of Health
- CLOSED Translational Center for Accelerating the Use of Digital Health Technologies Data in AD/ADRD Research — National Institutes of Health